Bernstein Reiterates Outperform on ServiceNow (NOW), Sees GenAI Upside Into H2 2026

ServiceNow, Inc. (NYSE:NOW) is one of the Buzzing AI Stocks Analysts are Watching. On January 20, Bernstein SocGen Group analyst Peter Weed reiterated an Outperform rating on the stock with a $219.00 price target. The firm is optimistic on NOW, citing upside catalysts in GenAI and H2 execution.

In an investor note, the firm highlighted how ServiceNow is one of the safest application stocks based on short interest metrics. This is despite having experienced sharper declines than most large-cap application peers since January 1.

Sometimes we feel like the ‘old man shouting at a cloud’ meme as we defend applications, and ServiceNow in particular.

While there have been concerns regarding NOW’s recent large acquisitions, the firm noted how applications remain relevant and that the acquisitions have been “wise.” As such, ServiceNow is the firm’s top application pick for the second half of 2026.

The firm’s CIO survey has also revealed strong customer support for the company over any application vendor, and that the company’s steady growth profile and low valuation support further upside, particularly from GenAI initiatives.

In particular, ServiceNow may even see incremental H2 revenue upside. Not just because they may show cross-sell synergy traction from Moveworks, but even more importantly the upside from their GenAI offers.

ServiceNow, Inc. (NYSE:NOW) provides an AI-native orchestration platform that integrates workflows, data, and AI to enable autonomous business operations.

While we acknowledge the potential of NOW as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 10 AI Stocks Making Waves on Wall Street and 10 AI Stocks on Market Radar

Disclosure: None.